Deal Spotlight
Nov 17, 2026

Biomatter raises EUR16.2M Series A backed by Astanor, Inventure, Metaplanet, UnternehmerTUM Venture Capital

EUR16.2M
round size
series-a
stage

The Series A round for Biomatter closed on November 1, 2026, with participation from Astanor, Inventure, Metaplanet, and UnternehmerTUM Venture Capital. The company has no previously recorded funding rounds.

Based in Lithuania, Biomatter operates within Healthcare & Life Sciences. The company has not disclosed founders or stage information and has not reported prior capital raised.

Brouky tracks two Healthcare & Life Sciences deals in Lithuania over the past year, with a median deal size of EUR38.0M.

Share this article

Related insights

Explore the full dataset

Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.